Seasonal Analysis for Moderna, Inc. (MRNA)
The following two tables show the seasonal performance of Moderna, Inc., with the stock symbol MRNA. The first table is a quarterly analysis. The second table is a semi-annual analysis that shows not only the two half-years but also the performance of the summer and winter half-years.
| Overview | 1st Quarter Jan. - Mar. |
2nd Quarter Apr. - Jun. |
3rd Quarter Jul. - Sep. |
4th Quarter Oct. - Dec. |
|---|---|---|---|---|
| Success Rate | 57.14% | 42.86% | 42.86% | 57.14% |
| Median Return | 7.15% | -2.68% | -6.38% | 14.17% |
| Average Return | 23.79% | 47.02% | 17.84% | 29.92% |
| Maximum Gain | 53.12% | 114.39% | 63.78% | 51.90% |
| Gain Year | 2020 | 2020 | 2021 | 2022 |
| Maximum Loss | -32.18% | -28.06% | -43.72% | -37.78% |
| Loss Year | 2022 | 2019 | 2024 | 2024 |
| Based on the past 7 years (2019-2025) | ||||
| Overview | Winter Season Oct. - Mar. |
Summer Season Apr. - Sep. |
First HY Jan. - Jun. |
Second HY Jul. - Dec. |
|---|---|---|---|---|
| Success Rate | 57.14% | 42.86% | 50.00% | 50.00% |
| Median Return | 10.66% | -4.53% | 2.24% | 2.51% |
| Average Return | 26.68% | 28.96% | 31.86% | 23.97% |
| Maximum Gain | 53.12% | 114.39% | 114.39% | 63.78% |
| Gain Year | 2020 | 2020 | 2020 | 2021 |
| Maximum Loss | -37.78% | -43.72% | -32.18% | -43.72% |
| Loss Year | 2024 | 2024 | 2022 | 2024 |
| Based on the past 7 years (2019-2025) | ||||